These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 18628576)
1. Lamivudine treatment improves the prognosis of fulminant hepatitis B. Miyake Y; Iwasaki Y; Takaki A; Fujioka S; Takaguchi K; Ikeda H; Kobashi H; Sakaguchi K; Shiratori Y Intern Med; 2008; 47(14):1293-9. PubMed ID: 18628576 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192 [TBL] [Abstract][Full Text] [Related]
3. Lamivudine treatment is associated with improved survival in fulminant hepatitis B. Yu JW; Sun LJ; Yan BZ; Kang P; Zhao YH Liver Int; 2011 Apr; 31(4):499-506. PubMed ID: 21382160 [TBL] [Abstract][Full Text] [Related]
4. Treatment of subacute hepatitis B with lamivudine: a pilot study in Serbia. Delić D; Nesić Z; Prostran M; Boricić I; Svirtlih N Vojnosanit Pregl; 2009 Mar; 66(3):199-202. PubMed ID: 19341224 [TBL] [Abstract][Full Text] [Related]
5. Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus Infection. Fujiwara K; Yasui S; Haga Y; Nakamura M; Yonemitsu Y; Arai M; Kanda T; Oda S; Yokosuka O; Kato N Intern Med; 2018 Jun; 57(11):1543-1552. PubMed ID: 29321429 [TBL] [Abstract][Full Text] [Related]
6. Lamivudine treatment for acute severe hepatitis B: report of a case and review of the literature. Roussos A; Koilakou S; Kalafatas I; Kalantzis C; Apostolou N; Grivas E; Raptis N; Mantzaris G Acta Gastroenterol Belg; 2008; 71(1):30-2. PubMed ID: 18396747 [TBL] [Abstract][Full Text] [Related]
7. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406 [TBL] [Abstract][Full Text] [Related]
8. Therapy of acute and fulminant hepatitis B. Tillmann HL; Patel K Intervirology; 2014; 57(3-4):181-8. PubMed ID: 25034486 [TBL] [Abstract][Full Text] [Related]
9. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure. Sun LJ; Yu JW; Zhao YH; Kang P; Li SC J Gastroenterol Hepatol; 2010 Mar; 25(3):583-90. PubMed ID: 19968744 [TBL] [Abstract][Full Text] [Related]
10. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Lee WC; Wu MJ; Cheng CH; Chen CH; Shu KH; Lian JD Am J Kidney Dis; 2001 Nov; 38(5):1074-81. PubMed ID: 11684562 [TBL] [Abstract][Full Text] [Related]
11. Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? Tillmann HL; Zachou K; Dalekos GN Liver Int; 2012 Apr; 32(4):544-53. PubMed ID: 22099371 [TBL] [Abstract][Full Text] [Related]
12. Acute fulminant hepatitis B in a patient with diabetic nephropathy treated successfully with concomitant lamivudine and molecular adsorbents recirculating system. Tsai SH; Chang HM; Hsieh CB; Chao YC; Hsieh TY J Infect; 2006 Jul; 53(1):e19-23. PubMed ID: 16269182 [TBL] [Abstract][Full Text] [Related]
13. Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: using virologic response at week 4. Xiang-Hui Y; Lang X; Yan Z; Li Z; Xiao-Feng S; Hong R Eur J Intern Med; 2014 Nov; 25(9):860-4. PubMed ID: 25439100 [TBL] [Abstract][Full Text] [Related]
14. Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B. Miyake Y; Iwasaki Y; Terada R; Takaguchi K; Sakaguchi K; Shiratori Y J Gastroenterol; 2007 Jun; 42(6):485-92. PubMed ID: 17671764 [TBL] [Abstract][Full Text] [Related]